Virtual Investor & Analyst Cell Therapy R&D Day to be held on November 14 at 10 am. Webcast Link
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PSTX:
- Poseida Therapeutics Reports Strong Q3 2024 Progress
- Poseida Therapeutics reports Q3 EPS 21c, consensus 41c
- Poseida Therapeutics to present data on P-KLKB1-101 in hereditary angioedema
- Poseida Therapeutics nominates new CAR-T candidate under Roche collaboration
- Poseida Therapeutics reports data from Phase 1 trial of P-BCMA-ALLO1